Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.37 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.37 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.36 |
| ▸ | AGXT | P21549 | 2/20 | 0.36 |
| ▸ | SLC11A2 | P49281 | 1/20 | 0.36 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.35 |
| ▸ | PNMT | P11086 | 1/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12345521 | 0.87 | TP53 (0.48) | CYP1A2GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL3526008 | 0.87 | TRPA1 (0.48) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| SCHEMBL3145457 | 0.87 | ENPP2 (0.50) | ENPP2NOS3NOS1NOS2 | |
| SCHEMBL4599484 | 0.87 | LOXL2 (0.55) | LOXL2TAAR1PNMTENPP2NOS3 | |
| SCHEMBL283775 | 0.83 | — | — | |
| SCHEMBL28644935 | 0.83 | TAAR1 (0.63) | LOXL2TAAR1PNMTCYP2D6NOS3 | |
| SCHEMBL28800741 | 0.83 | TDP1 (0.52) | MEN1KMT2ACYP1A1CYP1A2CYP1B1 | |
| SCHEMBL22048554 | 0.83 | CNR1 (0.42) | MEN1KMT2ATAAR1GRIN2DGRIN3B | |
| SCHEMBL1225353 | 0.81 | — | — | |
| SCHEMBL863771 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4351975-A | Process for preparing chlorinated compounds | CIBA-GEIGY AG (CH) | 1982-09-28 | — | — | US | claimed |
| US-12466786-B2 | Separation method | AGC Inc. (JP) | 2025-11-11 | — | — | US | disclosed |
| US-20250101228-A1 | COMPOSITION AND ARTICLE | DAIKIN INDUSTRIES, LTD. (JP) | 2025-03-27 | — | — | US | disclosed |
| EP-4512861-A1 | COMPOSITION AND ARTICLE | DAIKIN INDUSTRIES, LTD. (JP) | 2025-02-26 | — | — | EP | disclosed |
| CN-114650979-B | Compound, mixture, curable resin composition, cured product thereof, and method for producing compound | 日本化药株式会社 | 2024-09-17 | — | — | CN | disclosed |
| EP-4257593-A1 | CHIRAL MULTIDENTATE LIGAND AND USE THEREOF IN ASYMMETRIC HYDROGENATION | SHENZHEN CATALYS TECHNOLOGY CO., LTD. (CN) | 2023-10-11 | — | — | EP | disclosed |
| US-20230272156-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT | DIC CORPORATION (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20230250052-A1 | SEPARATION METHOD | AGC Inc. (JP) | 2023-08-10 | — | — | US | disclosed |
| CN-114650979-A | Compound, mixture, curable resin composition, cured product thereof, and method for producing compound | 日本化药株式会社 | 2022-06-21 | — | — | CN | disclosed |
| CN-114258412-A | Fluorine-containing compound, composition containing fluorine-containing compound, coating liquid, article, and method for producing article | ＡＧＣ株式会社 | 2022-03-29 | — | — | CN | disclosed |
| EP-0311387-B1 | AROMATIC AMINE RESINS, THEIR PRODUCTION PROCESS AND THERMOSETTING RESIN COMPOSITIONS MAKING USE OF THE SAME | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-08-11 | — | — | EP | disclosed |
| US-5145949-A | Production process for making aromatic amine resins | MITSUI TOATSU CHEMICALS, INC. (JP) | 1992-09-08 | — | — | US | disclosed |
| CN-1062544-A | The compositions of thermosetting resin that contains arylamino resin | MITSUI TOATSU CHEMICALS (JP) | 1992-07-08 | — | — | CN | disclosed |
| CN-1017055-B | Process for producing aromatic amine resin | MITSUI TOATSU CHEMICALS (JP) | 1992-06-17 | — | — | CN | disclosed |
| US-5106953-A | Reacting aromatic amines with bishalogenomethyl derivatives; curing agents or raw materials for polyamides | MITSUI TOATSU CHEMICALS, INC. (JP) | 1992-04-21 | — | — | US | disclosed |
| US-5051494-A | A bismaleimide and an amino resin | MITSUI TOATSU CHEMICALS, INC. (JP) | 1991-09-24 | — | — | US | disclosed |
| US-4937318-A | Aromatic amine resins | MITSUI TOATSU CHEMICALS, INC. (JP) | 1990-06-26 | — | — | US | disclosed |
| CN-1032806-A | Aromatic amine resin, its preparation method and application in thermosetting resin composition | MITSUI TOATSU CHEMICALS (JP) | 1989-05-10 | — | — | CN | disclosed |
| EP-0311387-A2 | Aromatic amine resins, their production process and thermosetting resin compositions making use of the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-04-12 | — | — | EP | disclosed |
| US-4351975-A | Process for preparing chlorinated compounds | CIBA-GEIGY AG (CH) | 1982-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12466786-B2 | Separation method | HAO2, FOXM1, PFN1 | MEN1 1038/4885KMT2A 2652/4885CYP1A1 663/4885 |
| US-20230250052-A1 | SEPARATION METHOD | PFDN6, PCLAF, PFDN2 | MEN1 2319/4885KMT2A 3537/4885CYP1A1 1183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.